Hypochloremia in chronic and acute heart failure scenarios: Prevalence and risk factors

Pau Llàcer1, Marta Cobo Marcos2, François Croset1

  • 1Internal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain; Department of Medicine and Medical Specialties, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, IRYCIS, Madrid, Spain.

Insights

Hypochloremia, or low chloride levels, is common in heart failure (HF) patients, particularly those acutely ill. Lower sodium, diuretic use, and higher CA125 are linked to low chloride in HF.

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Chloride is vital for fluid balance.
  • Hypochloremia is linked to poor outcomes and diuretic resistance in heart failure (HF).

Purpose of the Study:

  • To determine the prevalence of hypochloremia in chronic and acute heart failure (HF) patients.
  • To identify factors associated with low chloride levels in HF.

Main Methods:

  • Retrospective analysis of three heart failure (HF) cohorts.
  • Multivariate linear regression to identify factors associated with chloride levels.

Main Results:

  • Hypochloremia prevalence was 5.5% in chronic HF, 11% in ambulatory worsening HF (WHF), and 24% in inpatient WHF.
  • Lower plasma sodium, loop diuretic use, and higher CA125 were independently associated with lower chloride levels across all cohorts.

Conclusions:

  • Hypochloremia prevalence varies with clinical status in HF.
  • Low chloride levels in HF are associated with lower sodium, diuretic use, and elevated CA125.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
349
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
396
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
539
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
179